Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial

BACKGROUND: Patients with advanced oesophageal cancer have a median survival of 3–6 months, and most require intervention for dysphagia. Self-expanding metal stent (SEMS) insertion is the most typical form of palliation in these patients, but dysphagia deterioration and re-intervention are common. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamson, Douglas, Byrne, Anthony, Porter, Catharine, Blazeby, Jane, Griffiths, Gareth, Nelson, Annmarie, Sewell, Bernadette, Jones, Mari, Svobodova, Martina, Fitzsimmons, Deborah, Nixon, Lisette, Fitzgibbon, Jim, Thomas, Stephen, Millin, Anthony, Crosby, Tom, Staffurth, John, Hurt, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955283/
https://www.ncbi.nlm.nih.gov/pubmed/33610215
http://dx.doi.org/10.1016/S2468-1253(21)00004-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955283/
https://www.ncbi.nlm.nih.gov/pubmed/33610215
http://dx.doi.org/10.1016/S2468-1253(21)00004-2

Ejemplares similares